Financhill
Back

Sorrento Therapeutics Quote, Financials, Valuation and Earnings

Sorrento Therapeutics Price Quote

$0.0200
+0.0050 (+33.33%)
(Updated: May 2, 2024 at 10:40 AM ET)

Sorrento Therapeutics Key Stats

Sell
44
Sorrento Therapeutics (SRNE) is a Sell

Day range:
$0.0130 - $0.0220
52-week range:
$0.0001 - $0.4190
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
369.8K
Avg. volume:
240.5K
1-year change:
-94.76%
Market cap:
$8.3M
Revenue:
$62.8M
EPS:
$-1.12

How Much Does Sorrento Therapeutics Make?

Is Sorrento Therapeutics Growing As A Company?

  • What Is Sorrento Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.31%
  • What Is Sorrento Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Sorrento Therapeutics Stock Price Performance

What Is Sorrento Therapeutics 52-Week High & Low?

Sorrento Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sorrento Therapeutics?

Is Sorrento Therapeutics Cash Flow Positive?

  • What Is SRNE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$234.6M
  • What Is Sorrento Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $246.6M
  • What Is Sorrento Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$11.6M

Sorrento Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    SRNE return on invested capital is -794.42%
  • What Is Sorrento Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -103.91%
  • What Is SRNE Return On Equity?
    ROE is a measure of profitability and is 0%

Sorrento Therapeutics Earnings Date & Stock Price

Sorrento Therapeutics Competitors

Sorrento Therapeutics Dividend Yield

Data Unavailable

Sorrento Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 31.1% -18.75%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 13.0000
Upside from Last Price: 86566.67%

Major Shareholders

  • How many SRNE shares are owned by institutional investors?
    15.1M SRNE shares are owned by institutional investors
  • How many SRNE shares are owned by insiders?
    109M SRNE shares are owned by insiders